| News

Botnar Research Center advancing research into coronavirus

30.03.2020

The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.

3D rendering of a microscopic image of the novel coronavirus SARS-CoV-2 (img: Creativeneko/123rf)

The Botnar Research Center for Child Health (BRCCH) was founded by the University of Basel and the Swiss Federal Institute of Technology in Zurich (ETH). The University Children’s Hospital Basel (UKBB) and the Swiss Tropical and Public Health Institute (Swiss TPH), which is likewise based in Basel, are also involved with the center. BRCCH is now providing its four partner institutions with 15 million Swiss francs to facilitate research into the coronavirus, as detailed in a press release issued by the University of Basel.

The funding is to be provided by the Foundation Botnar as part of a first emergency initiative organized by the BRCCH, which was opened in 2019. Within the framework of this initiative, projects “dealing with the diagnosis and human immune response to COVID-19, as well as to projects in the fields of medical interventions and disease management” are to be supported over the next two-and-a-half years.

The BRCCH initiative will focus on two objectives: first, to come up with solutions to urgent problems in the fight against the pandemic and, second, to develop long-term approaches “so that similar situations can be better managed worldwide in the future”.

Click here for other events that shaped the Basel Area in 2020

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
RocketVax secures partners for coronavirus vaccine in Basel
Basel Area Business & Innovation, Innovation

RocketVax secures partners for coronavirus vaccine in Basel

RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...

Read More
Bright Peak secures investment of 107 million dollars
Basel Area Business & Innovation, Innovation, Invest

Bright Peak secures investment of 107 million dollars

Bright Peak has raised a total of 107 million US dollars as part of a financing round. The biotechnology firm...

Read More
LCB lands major contract
Basel Area Business & Innovation, Innovation, Invest

LCB lands major contract

LCB Sàrl is active in the areas of Human Machine Interface as well as software and electronics development. The company...

Read More
1 2 3 28

Do you have a question? We'd like to hear from you.